GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Volpara Health Technologies Ltd (OTCPK:VPAHF) » Definitions » EV-to-EBIT

Volpara Health Technologies (Volpara Health Technologies) EV-to-EBIT : -28.31 (As of Jun. 04, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Volpara Health Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Volpara Health Technologies's Enterprise Value is $189.19 Mil. Volpara Health Technologies's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-6.68 Mil. Therefore, Volpara Health Technologies's EV-to-EBIT for today is -28.31.

The historical rank and industry rank for Volpara Health Technologies's EV-to-EBIT or its related term are showing as below:

VPAHF' s EV-to-EBIT Range Over the Past 10 Years
Min: -30.13   Med: -13.87   Max: -3.08
Current: -27.85

During the past 7 years, the highest EV-to-EBIT of Volpara Health Technologies was -3.08. The lowest was -30.13. And the median was -13.87.

VPAHF's EV-to-EBIT is ranked worse than
100% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 17.52 vs VPAHF: -27.85

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Volpara Health Technologies's Enterprise Value for the quarter that ended in Sep. 2023 was $109.57 Mil. Volpara Health Technologies's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-6.68 Mil. Volpara Health Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -6.10%.


Volpara Health Technologies EV-to-EBIT Historical Data

The historical data trend for Volpara Health Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Volpara Health Technologies EV-to-EBIT Chart

Volpara Health Technologies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
Get a 7-Day Free Trial -21.20 -9.54 -17.48 -13.90 -17.79

Volpara Health Technologies Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -13.90 - -17.79 -

Competitive Comparison of Volpara Health Technologies's EV-to-EBIT

For the Health Information Services subindustry, Volpara Health Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Volpara Health Technologies's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Volpara Health Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Volpara Health Technologies's EV-to-EBIT falls into.



Volpara Health Technologies EV-to-EBIT Calculation

Volpara Health Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=189.191/-6.684
=-28.31

Volpara Health Technologies's current Enterprise Value is $189.19 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Volpara Health Technologies's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-6.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Volpara Health Technologies  (OTCPK:VPAHF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Volpara Health Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 ) =EBIT / Enterprise Value (Q: Sep. 2023 )
=-6.684/109.5743
=-6.10 %

Volpara Health Technologies's Enterprise Value for the quarter that ended in Sep. 2023 was $109.57 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Volpara Health Technologies's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-6.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Volpara Health Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Volpara Health Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Volpara Health Technologies (Volpara Health Technologies) Business Description

Traded in Other Exchanges
Address
40 Mercer Street, Level 14–15, Wellington Central, Wellington, NZL, 6011
Volpara Health Technologies Ltd is a New Zealand-based research, development, and manufacturing company. The business of the company operates through three product categories that include Capital Sales, Software Maintenance Agreements, and Software as a Service. It offers a breast imaging analytics platform that delivers real-time quality assurance and performance monitoring. It operates through the sale of a single suite of medical device software products.